Pollyea DA, Bixby D, Perl A, Bhatt VR, Altman JK, Appelbaum FR, de Lima M, Fathi AT, Foran JM, Gojo I, Hall AC, Jacoby M, Lancet J, Mannis G, Marcucci G, Martin MG, Mims A, Neff J, Nejati R, Olin R, Percival M-E, Prebet T, Przespolewski A, Rao D, Ravandi-Kashani F, Shami PJ, Stone RM, Strickland SA, Sweet K, Vachhani P, Wieduwilt M, Gregory KM, Ogba N, Tallman MS. NCCN guidelines insights: acute myeloid leukemia, Version 2.2021. J Natl Compr Cancer Netw JNCCN. 2021;19:16–27. https://doi.org/10.6004/jnccn.2021.0002.

Article  PubMed  Google Scholar 

Jin X, Zhang M, Sun R, Lyu H, Xiao X, Zhang X, Li F, Xie D, Xiong X, Wang J, Lu W, Zhang H, Zhao M. First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia. J Hematol OncolJ Hematol Oncol. 2022;15:88. https://doi.org/10.1186/s13045-022-01308-1.

Article  Google Scholar 

Wang Q, Wang Y, Lv H, Han Q, Fan H, Guo B, Wang L, Han W. Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia. Mol Ther. 2015;23:184–91. https://doi.org/10.1038/mt.2014.164.

Article  PubMed  Google Scholar 

Gallazzi M, Ucciero MAM, Faraci DG, Mahmoud AM, Al Essa W, Gaidano G, Mouhssine S, Crisà E. New frontiers in monoclonal antibodies for the targeted therapy of acute myeloid leukemia and myelodysplastic syndromes. Int J Mol Sci. 2022;23:7542. https://doi.org/10.3390/ijms23147542.

Article  PubMed  PubMed Central  Google Scholar 

Abaza Y, Zeidan AM. Immune checkpoint inhibition in acute myeloid leukemia and myelodysplastic syndromes. Cells. 2022;11:2249. https://doi.org/10.3390/cells11142249.

Article  PubMed  PubMed Central  Google Scholar 

Riether C, Pabst T, Höpner S, Bacher U, Hinterbrandner M, Banz Y, Müller R, Manz MG, Gharib WH, Francisco D, Bruggmann R, van Rompaey L, Moshir M, Delahaye T, Gandini D, Erzeel E, Hultberg A, Fung S, de Haard H, Leupin N, Ochsenbein AF. Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents. Nat Med. 2020;26:1459–67. https://doi.org/10.1038/s41591-020-0910-8.

Article  PubMed  Google Scholar 

Zhou H, Wang F, Niu T. Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia. Front Nutr. 2022;9:1056648. https://doi.org/10.3389/fnut.2022.1056648.

Article  PubMed  PubMed Central  Google Scholar 

Gregory MA, Nemkov T, Park HJ, Zaberezhnyy V, Gehrke S, Adane B, Jordan CT, Hansen KC, D’Alessandro A, DeGregori J. Targeting glutamine metabolism and redox state for leukemia therapy. Clin Cancer Res Off J Am Assoc Cancer Res. 2019;25:4079–90. https://doi.org/10.1158/1078-0432.CCR-18-3223.

Article  Google Scholar 

Yang L, Venneti S, Nagrath D. Glutaminolysis: a hallmark of cancer metabolism. Annu Rev Biomed Eng. 2017;19:163–94. https://doi.org/10.1146/annurev-bioeng-071516-044546.

Article  PubMed  Google Scholar 

Darmaun D, Matthews DE, Bier DM. Glutamine and glutamate kinetics in humans. Am J Physiol. 1986;251:E117-126. https://doi.org/10.1152/ajpendo.1986.251.1.E117.

Article  PubMed  Google Scholar 

Rex MR, Williams R, Birsoy K, Ta Llman MS, Stahl M. Targeting mitochondrial metabolism in acute myeloid leukemia. Leuk Lymphoma. 2022;63:530–7. https://doi.org/10.1080/10428194.2021.1992759.

Article  PubMed  Google Scholar 

Wang M, Zhao A, Li M, Niu T. Amino acids in hematologic malignancies: current status and future perspective. Front Nutr. 2023;10:1113228. https://doi.org/10.3389/fnut.2023.1113228.

Article  PubMed  PubMed Central  Google Scholar 

Emadi A. Exploiting AML vulnerability: glutamine dependency. Blood. 2015;126:1269–70. https://doi.org/10.1182/blood-2015-07-659508.

Article  PubMed  Google Scholar 

Petronini PG, Urbani S, Alfieri R, Borghetti AF, Guidotti GG. Cell susceptibility to apoptosis by glutamine deprivation and rescue: survival and apoptotic death in cultured lymphoma-leukemia cell lines. J Cell Physiol. 1996;169:175–85. https://doi.org/10.1002/(SICI)1097-4652(199610)169:1%3c175::AID-JCP18%3e3.0.CO;2-C.

Article  PubMed  Google Scholar 

Schulze A, Harris AL. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature. 2012;491:364–73. https://doi.org/10.1038/nature11706.

Article  PubMed  Google Scholar 

Saha SK, Islam SMR, Abdullah-AL-Wadud M, Islam S, Ali F, Park KS. Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer. J Clin Med. 2019;8:355. https://doi.org/10.3390/jcm8030355.

Article  PubMed  PubMed Central  Google Scholar 

Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci USA. 2010;107:7455–60. https://doi.org/10.1073/pnas.1001006107.

Article  PubMed  PubMed Central  Google Scholar 

Lane DP. Cancer. p53, guardian of the genome. Nature. 1992;358:15–6. https://doi.org/10.1038/358015a0.

Article  PubMed  Google Scholar 

Suzuki S, Tanaka T, Poyurovsky MV, Nagano H, Mayama T, Ohkubo S, Lokshin M, Hosokawa H, Nakayama T, Suzuki Y, Sugano S, Sato E, Nagao T, Yokote K, Tatsuno I, Prives C. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci USA. 2010;107:7461–6. https://doi.org/10.1073/pnas.1002459107.

Article  PubMed  PubMed Central  Google Scholar 

Giacobbe A, Bongiorno-Borbone L, Bernassola F, Terrinoni A, Markert EK, Levine AJ, Feng Z, Agostini M, Zolla L, Agrò AF, Notterman DA, Melino G, Peschiaroli A. p63 regulates glutaminase 2 expression. Cell Cycle. 2013;12:1395–405. https://doi.org/10.4161/cc.24478.

Article  PubMed  PubMed Central  Google Scholar 

Velletri T, Romeo F, Tucci P, Peschiaroli A, Annicchiarico-Petruzzelli M, Niklison-Chirou MV, Amelio I, Knight RA, Mak TW, Melino G, Agostini M. GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation. Cell Cycle. 2013;12:3564–73. https://doi.org/10.4161/cc.26771.

Article  PubMed  PubMed Central  Google Scholar 

Hung C-L, Wang L-Y, Yu Y-L, Chen H-W, Srivastava S, Petrovics G, Kung H-J. A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci USA. 2014;111:18697–702. https://doi.org/10.1073/pnas.1415669112.

Article  PubMed  PubMed Central  Google Scholar 

Gao P, Tchernyshyov I, Chang T-C, Lee Y-S, Kita K, Ochi T, Zeller K, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism. Nature. 2009;458:762–5. https://doi.org/10.1038/nature07823.

Article  PubMed  PubMed Central  Google Scholar 

Dernie F. Characterisation of a mitochondrial glutamine transporter provides a new opportunity for targeting glutamine metabolism in acute myeloid leukaemia. Blood Cells Mol Dis. 2021;88: 102422. https://doi.org/10.1016/j.bcmd.2020.102422.

Article  PubMed  Google Scholar 

Cormerais Y, Massard PA, Vucetic M, Giuliano S, Tambutté E, Durivault J, Vial V, Endou H, Wempe MF, Parks SK, Pouyssegur J. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5). J Biol Chem. 2018;293:2877–87. https://doi.org/10.1074/jbc.RA117.001342.

Article  PubMed  PubMed Central  Google Scholar 

Teixeira E, Silva C, Martel F. The role of the glutamine transporter ASCT2 in antineoplastic therapy. Cancer Chemother Pharmacol. 2021;87:447–64. https://doi.org/10.1007/s00280-020-04218-6.

Article  PubMed  Google Scholar 

Ni F, Yu W-M, Li Z, Graham DK, Jin L, Kang S, Rossi MR, Li S, Broxmeyer HE, Qu C-K. Critical role of ASCT2-mediated amino acid metabolism in promoting leukaemia development and progression. Nat Metab. 2019;1:390–403. https://doi.org/10.1038/s42255-019-0039-6.

Article  PubMed  PubMed Central  Google Scholar 

Schulte ML, Fu A, Zhao P, Li J, Geng L, Smith ST, Kondo J, Coffey RJ, Johnson MO, Rathmell JC, Sharick JT, Skala MC, Smith JA, Berlin J, Washington MK, Nickels ML, Manning HC. Pharmacological blockade of ASCT2-dependent glutamine transport leads to anti-tumor efficacy in preclinical models. Nat Med. 2018;24:194–202. https://doi.org/10.1038/nm.4464.

Article  PubMed  PubMed Central